ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta? portfolio
pharmafocusasia
November 12, 2018Vectura Group plc, today announces signing an agreement with Hikma Pharmaceuticals PLC ("Hikma") for the global development and commercialisation of generic versions of GSK’s Ellipta? portfolio, utilising Vectura’s proprietary Open-Inhale-Close dry powder -
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta? portfolio
pharmafocusasia
November 12, 2018Vectura Group plc, today announces signing an agreement with Hikma Pharmaceuticals PLC ("Hikma") for the global development and commercialisation of generic versions of GSK’s Ellipta? portfolio, utilising Vectura’s proprietary Open-Inhale-Close dry powder -
Glenmark to market Tiotropium Bromide dry powder inhaler in Western Europe
expressbpd
August 30, 2018Glenmark Pharmaceuticals Europe has entered into a strategic, exclusive licensing agreement for marketing generic Tiotropium Bromide dry powder inhaler, used in the treatment of chronic obstructive pulmonary disease, in Western Europe.
Pharma Sources Insight January 2025
